Sun Pharmaceutical Entered Into Joint Venture with Intrexon Corporation

Sun Pharmaceutical Industries India's biggest drug maker by market capital and USA based Intrexon Corporation, a leading player in synthetic biology announced

Created On: Oct 3, 2013 12:35 ISTModified On: Oct 3, 2013 15:34 IST

Sun Pharmaceutical Industries India's biggest drug maker by market capital and USA based Intrexon Corporation, a leading player in synthetic biology announced on 2 October 2013 to establish a joint venture to develop controllable gene-based therapies for the treatment of eye diseases.

The joint venture will helpful for Sun Pharma's  to increase their global capabilities and experience in developing and manufacturing complex dosage forms .It will also enhance their specialty pharmaceuticals for niche therapy areas.

The partners will initially work on  age related macular degeneration ( AMD)(a medical condition that causes partial or full loss of vision among older adults), glaucoma(a kind of eye disease) and retinitis pigmentosa(an eye disease that causes severe vision loss and at times even blindness).

Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

एग्जाम की तैयारी के लिए ऐप पर वीकली टेस्ट लें और दूसरों के साथ प्रतिस्पर्धा करें। डाउनलोड करें करेंट अफेयर्स ऐप

AndroidIOS
Comment ()

Post Comment

6 + 1 =
Post

Comments